Wednesday, 2 September 2020

Zydus Cadila receives final approval from the USFDA for Cisatracurium Besylate Injection

Zydus Cadila has received final approval from the USFDA to market Cisatracurium Besylate Injection USP (US RLD: Nimbex ®) in the strength of 20 mg (base)/10 mL (2 mg/mL) Multiple-Dose Vial.



source https://www.pharmatutor.org/pharma-news/2020/zydus-cadila-receives-final-approval-from-the-usfda-for-cisatracurium-besylate-injection
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharmaceutical jobs for MPharm / MSc / BPharm or BSc - DPharm or PharmD and PhD

  Openings for Pharmacists under the National Health Mission Degree or Diploma in Pharmacy (50%) & Registration in CG Pharmacy Registrat...